Hims & Hers appoints Christopher Payne to board of directors

Hims & Hers Health, Inc.

Board expanded from 9 to 10; Christopher Payne, 55, appointed effective March 30, 2024.
Payne deemed independent under NYSE and SEC standards; no committee assignments yet.
Initial RSU award valued at $400,000 under director compensation program; standard indemnification agreement entered.
No arrangements or family relationships with directors/officers; no transactions requiring disclosure under Item 404(a).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher Payne

Director

HIMS · Hims & Hers Health, Inc.

Effective: 2024-03-30
Filed: April 3, 2024, 7:59 PM ET

On March 30, 2024, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Christopher Payne, 55, to fill the newly created vacancy, effective March 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Christopher Payne was appointed as Director at Hims & Hers Health, Inc..

Action: appointed
Role: Director

Exact text from the filing

On March 30, 2024, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Christopher Payne, 55, to fill the newly created vacancy, effective March 30, 2024.

View on SEC.gov

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-24-000093

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.